Indivior Share Price | |
---|---|
Price | 1,392.00 |
Bid | 1,391.00 |
Ask | 1,394.00 |
Change | -16.00 (-1.14%) |
Volume | 76,686 |
Open | 1,410.00 |
High | 1,418.00 |
Low | 1,382.00 |
Prev. Close | 1,408.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 135.44m |
Market Capitalisation | £1.89b |
Market Size | 1,500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 297 |
---|---|
Vol. Sold | 34,482 |
Sold Value | £479.77k |
Vol. Bought | 27,538 |
Bought Value | £383.92k |
PE Ratio | 1,772.28663 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
29-Apr-24 | 09:55:56 | 1,394.24 | 4,303 | Buy* | 1,391.00 | 1,394.00 | 59.99k | O Ordinary |
29-Apr-24 | 09:55:53 | 1,394.00 | 5 | Buy* | 1,391.00 | 1,394.00 | 69.70 | O Ordinary Trade was executed as an SI |
29-Apr-24 | 09:48:27 | 1,392.00 | 28 | Sell* | 1,392.00 | 1,394.00 | 389.76 | A Automatic Execution |
29-Apr-24 | 09:48:26 | 1,393.00 | 52 | Buy* | 1,391.00 | 1,394.00 | 724.36 | A Automatic Execution |
29-Apr-24 | 09:48:26 | 1,393.00 | 143 | Buy* | 1,390.00 | 1,393.00 | 1,992 | A Automatic Execution |
29-Apr-24 | 09:48:26 | 1,393.00 | 13 | Buy* | 1,390.00 | 1,393.00 | 181.09 | A Automatic Execution |
29-Apr-24 | 09:48:26 | 1,393.00 | 126 | Buy* | 1,390.00 | 1,393.00 | 1,755 | A Automatic Execution |
29-Apr-24 | 09:48:26 | 1,393.00 | 4 | Buy* | 1,390.00 | 1,393.00 | 55.72 | A Automatic Execution |
29-Apr-24 | 09:48:22 | 1,391.00 | 50 | Sell* | 1,391.00 | 1,394.00 | 695.50 | A Automatic Execution |
29-Apr-24 | 09:48:22 | 1,391.00 | 137 | Sell* | 1,391.00 | 1,394.00 | 1,906 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
18-Mar-24 | 15-Mar-24 | Exercise of Option | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 555.00 | GBX | 15,444 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.